Industrial & pharma EDI — Nestlé, Novartis, Roche, ABB, Lonza, Sika
Switzerland hosts world champions in food, pharma and industry. All have exchanged in EDI with their suppliers and distributors for decades. For the newcomer: behind a Roche medicine box or a Nestlé bar, an EDIFACT flow has already carried the order, the dispatch advice and the invoice — often enriched, in pharma, with unique serial numbers for traceability.
History — multinationals as EDI pioneers
Nestlé (Vevey), Novartis and Roche (Basel) are among the world's earliest adopters of EDIFACT EDI, from the 1990s. ABB (Zurich/Baden) and Sika (Baar) generalised EDI and OFTP2 over the ENX industrial network. Lonza (Basel/Visp), a pharma contract-manufacturing (CDMO) giant, structures its entire chain in EDI.
Pharma added a layer: serialisation — each box carries a unique serial number as a data matrix, to fight counterfeiting and enable targeted recalls. In Switzerland, the regime falls under Swissmedic, distinct from the EU system (FMD/EMVS) but aligned with the same spirit.
1990s | Nestlé, Novartis (formed from the 1996 Ciba-Geigy + Sandoz
| merger) and Roche roll out EDIFACT EDI with their global
| suppliers and distributors.
|
2000-2010 | ABB and Sika generalise EDI / OFTP2 over the ENX industrial
| network; Lonza structures its pharma CDMO chain in EDI.
|
2011-2019 | GS1 Healthcare standardises pharma identification (GTIN, GLN,
| SSCC) and item-level serialisation (unique serial numbers).
|
2019-2024 | Pharma serialisation: deployment of unique serial numbers and
| data matrix on boxes, under the Swissmedic regime (aligned with
| the spirit of the EU FMD without falling under it).
|
2024-2026 | Mature industrial EDI: coexistence of EDIFACT (operational B2B)
| + structured e-invoice for cross-border flows with the EU. Governance — GS1, Swissmedic, ENX
Three authorities frame this landscape: GS1 Switzerland Healthcare (pharma identification and serialisation standards), Swissmedic (Swiss Agency for Therapeutic Products — authorisation and supervision), and the ENX Association (a secure cross-industry network for OFTP2 flows, mainly in automotive and heavy industry).
Schema — EDIFACT, pharma serialisation
The dispatch advice (DESADV) is central in industry: it carries the packaging hierarchy (SSCC), the product GTIN, the batch number and the expiry date — critical data for pharma traceability:
UNH+1+DESADV:D:96A:UN:EAN005'
BGM+351+ASN-2026-77310+9'
DTM+11:202606161200:203'
NAD+SU+7613000000002::9' ← sender (Lonza/Roche GLN)
NAD+ST+7611000000005::9' ← recipient (warehouse GLN)
CPS+1'
PAC+12++201' ← 12 cartons
PCI+33E'
GIN+BJ+376123456789012345' ← SSCC (logistics unit number)
LIN+1++07612345678901:SRV' ← GTIN-14 of the pharma product
QTY+12:480'
PIA+1+LOT-2026-0512:NB' ← batch no.
DTM+361:20281231:102' ← expiry date
UNT+13+1' Pharma vs heavy industry vs retail
| Dimension | Pharma (Novartis, Roche, Lonza) | Heavy industry (ABB, Sika) | Retail (Migros, Coop) |
|---|---|---|---|
| Standard | EDIFACT + GS1 Healthcare | EDIFACT / OFTP2 / ENX | EANCOM |
| Identifiers | GTIN + item serialisation | GLN / GTIN / SSCC | GLN / GTIN |
| Traceability | Batch + serial + expiry (Swissmedic) | Batch + SSCC | Batch (fresh) |
| Transport | AS2 / VAN | OFTP2 over ENX | VAN / AS2 |
| Regulator | Swissmedic | — | — |
Adoption — verticals and transport
- Food: Nestlé drives global EDI flows, with a GS1 data pool for product quality.
- Pharma: Novartis, Roche and Lonza combine B2B EDIFACT with Swissmedic item serialisation.
- Heavy industry: ABB and Sika rely on OFTP2/ENX, inherited from automotive and electrotechnical chains.
- Cross-border: for the EU, EDIFACT flows coexist with structured e-invoicing (PEPPOL, Factur-X, FatturaPA) depending on the customer country.
Common pitfalls
- Forgetting batch and expiry. In pharma/food, a DESADV without batch number or expiry date is unusable for traceability.
- Confusing serialisation and EDI. Item serialisation is a registry distinct from the EDI logistics flow; the two must be consistent.
- Wrong transport network. OFTP2 over ENX (industry) ≠ AS2/VAN (retail/pharma); the wrong channel blocks the exchange.
- Ignoring the Swissmedic / EU gap. A Swiss exporter to the EU must handle both the Swissmedic regime and the destination market's FMD/EMVS requirements.